缩水规模排第一！交银施罗德“三剑客”集体滑铁卢

Core Viewpoint - The company, Jiao Yin Schroder Fund, has experienced a significant decline in its public fund management scale and profitability, losing its status as a benchmark in equity investment, amidst increasing competition and internal management changes [5][6][14]. Group 1: Fund Management Scale - As of the end of 2025, Jiao Yin Schroder's public fund management scale was 5026.46 billion yuan, a decrease of 6.54% from 2024, ranking 25th in the industry [5][8]. - The overall public fund management scale in China reached a historical high of 37.71 trillion yuan by the end of 2025, increasing by 4.88 trillion yuan from the end of 2024 [5][41]. - The equity fund management scale has been in a downward trend since 2022, dropping from a peak of 2123.92 billion yuan in 2021 to 888.73 billion yuan by the end of 2025, a reduction of 1235.19 billion yuan [10][42]. Group 2: Profitability Decline - The company's net profit has been declining for several years, with a 16.7% year-on-year decrease in the first half of 2025, amounting to 4.09 billion yuan [6][14]. - Management fee income, a primary revenue source, fell to 10.93 billion yuan in the first half of 2025, down 12.53% year-on-year [16][49]. - From 2022 to the first half of 2025, the company's stock investment returns totaled -378 billion yuan, indicating a severe loss in profitability [51]. Group 3: Performance of Key Fund Managers - The so-called "Three Musketeers" of Jiao Yin Schroder, namely He Shuai, Wang Chong, and Yang Hao, have seen their managed funds underperform significantly against benchmarks, with returns lagging by over 20 percentage points in recent years [7][52]. - He Shuai's managed products reported a three-year return of -16.22%, while Wang Chong's funds also showed poor performance, with significant losses recorded [20][57]. - Yang Hao's only managed product, Jiao Yin New Vitality A, has consistently underperformed, with a maximum drawdown of -54.18% over five years [59]. Group 4: Management Changes - The company has undergone frequent personnel changes, including the departure of key executives and fund managers, which has added pressure to its investment research capabilities [27][30]. - Notable changes include the resignation of former General Manager Xie Wei and the appointment of Yuan Qingwei, who lacks prior experience in public funds [28][62]. - The investment research team has also seen significant turnover, with several long-tenured managers leaving, impacting the company's overall investment strategy [64][66].